Insulin analogues and cancer risk: the emergence of second-generation studies

Long-term effects of insulin glargine on the risk of breast cancer

(2011) S. Suissa et al.   DIABETOLOGIA

Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias

(2011) J. A. Johnson et al.   DIABETOLOGIA

Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry

(2010) X. Yang et al.   DIABETES

Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe

(2010) Andrew G. Renehan et al.   EUROPEAN JOURNAL OF CANCER

Linking diabetes and cancer: a consensus on complexity

(2010) Andrew Renehan et al.   LANCET

Does diabetes therapy influence the risk of cancer?

(2009) U. Smith et al.   DIABETOLOGIA

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

(2009) J. M. Jonasson et al.   DIABETOLOGIA

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

(2009) H. M. Colhoun et al.   DIABETOLOGIA

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

(2009) L. G. Hemkens et al.   DIABETOLOGIA

Insulin glargine and malignancy: an unwarranted alarm

(2009) Stuart J Pocock et al.   LANCET